DNA Methylation

Introduction

Dna Methylation is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

DNA methylation is an epigenetic modification involving the addition of a methyl group to the 5-position of cytosine residues in DNA (forming 5-methylcytosine, 5mC). This reversible, heritable modification regulates gene expression without altering the underlying DNA sequence and plays crucial roles in brain development, neuronal identity, synaptic plasticity, and aging. Aberrant DNA methylation patterns are increasingly recognized as a core feature of Alzheimer’s disease and other neurodegenerative disorders, linking environmental exposures and aging to altered gene expression and neuronal vulnerability (Coppieters et al., 2014; Day & Bhatt, 2024). ^{1Portela A, Esteller M. Epigenetic modifications and human disease. *Nat Biotechnol*. 2010;28:1057-1068. PubMed2010 · PMID 22293439Open reference}

DNA methylation is part of a broader epigenetic landscape that includes histone modifications, non-coding RNA regulation, and chromatin remodeling, all of which interact to determine gene expression states in the aging and diseased brain. ^{2Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. *PLoS One*. 2010;5:e15367. PubMed2010 · PMID 22353756Open reference}

Molecular Mechanisms

DNA Methyltransferases (DNMTs)

Three major DNMT enzymes catalyze methylation reactions (Portela & Esteller, 2010): ^{3Day JJ, Sweatt JD. Epigenetic mechanisms in cognition. *Nat Rev Neurosci*. 2015;16:661-675. PubMed2015 · PMID 26043950Open reference}

| Enzyme | Type | Key Function | Brain Expression | ^{4Day K, Bhatt DK. DNA methylation: the epigenetic mechanism of Alzheimer''s Disease. *Neurosci Bull*. 2024. PubMed2024Open reference} |--------|------|-------------|-----------------| ^{5CitationDOI 10.1038/s41467-022-33394-7Open reference} | DNMT1 | Maintenance | Copies methylation patterns to daughter strands during DNA replication | High in post-mitotic Neurons; maintains neuronal identity | ^{6Horvath S. DNA methylation age of human tissues and cell types/cell-types). *Genome Biol*. 2013;14:R115. . DOI2013 · DOI 10.1186/gb-2013-14-10-r115Open reference} | DNMT3A | De novo | Establishes new methylation marks | Active in adult neurogenesis and synaptic plasticity | ^{7Epigenetic regulation in neurodegeneration. *J Neurochem*. 2018;144:124-138. PubMed2018 · PMID 29358856Open reference} | DNMT3B | De novo | Establishes methylation during embryonic development | Lower postnatal expression; variants linked to ICF syndrome | ^{8CitationDOI 10.1038/nn.3639Open reference} | DNMT3L | Regulatory | Stimulates DNMT3A/B activity; lacks catalytic domain | Important in genomic imprinting | ^{9An epigenetic biomarker of aging for lifespan and healthspan2018 · Aging}

Methylation and Demethylation Cycle

DNA methylation is a dynamic, reversible process: ^{10npj Dementia. DNA methylation age from peripheral blood predicts progression to Alzheimer's Disease. *npj Dementia*. 2025. . DOI2025 · DOI 10.1038/s44400-025-00007-1Open reference}

1. Methylation: DNMTs transfer a methyl group from S-adenosylmethionine (SAM) to cytosine at CpG dinucleotides

2. Oxidation: TET (Ten-Eleven Translocation) enzymes oxidize 5mC to 5-hydroxymethylcytosine (5hmC), then to 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC)

3. Demethylation: Thymine DNA glycosylase (TDG) excises 5fC and 5caC; base excision repair (BER) restores unmodified cytosine

5-hydroxymethylcytosine (5hmC) is particularly abundant in the brain — approximately 10-fold higher than other tissues — and is enriched at active gene bodies and enhancers, where it serves as a stable epigenetic mark rather than merely a transient intermediate (Globisch et al., 2010). ^{2Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. *PLoS One*. 2010;5:e15367. PubMed2010 · PMID 22353756Open reference}0

CpG Context and Gene Regulation

Methylation Context	Effect on Expression	Brain Relevance
CpG island promoters	Methylation → silencing	Controls expression of synaptic and neuronal identity genes
Gene bodies	Methylation → active transcription	Regulates alternative splicing; enriched for 5hmC in Neurons
Enhancers	Cell-type-specific methylation patterns	Determines neurons vs. glia] gene expression programs
Non-CpG (CpH) methylation	Unique to Neurons; brain-specific	Accumulates during postnatal brain maturation; may regulate neuronal gene expression
Repetitive elements	Methylation maintains silencing	Loss of methylation at LINE-1 elements linked to aging and neurodegeneration

DNA Methylation in the Brain

Neurons-Specific Epigenetic Landscape

The brain exhibits unique methylation characteristics not seen in other tissues:

• High 5hmC levels: Brain has the highest 5hmC content of any organ, particularly in Neurons of the cortex, hippocampus, and cerebellum

• Non-CpG methylation: Neurons accumulate substantial CpH methylation (CpA, CpT, CpC) during postnatal development — a feature unique to brain cells

• Cell-type specificity: Dramatic differences in methylation patterns between Neurons, Astrocytes, [microglia:

• Global DNA hypomethylation in vulnerable regions (hippocampus, entorhinal cortex, [prefrontal [cortex)

• Reduced 5hmC levels, particularly in hippocampal Neurons

• Epigenome-wide association studies (EWAS) have identified hundreds of differentially methylated positions (DMPs) associated with AD neuropathology

• Cell-type deconvolution reveals that many DMPs in bulk cortex tissue reflect methylation changes in non-neuronal cells (microglia/cell-types/microglia:**

• BDNF: Reduced trophic support for hippocampal and cortical Neurons

• ANK1: Consistently identified as hypermethylated in the entorhinal cortex; one of the most robust EWAS findings in AD

• HOXA3, BIN1, RHBDF2: Genome-wide significant DMPs replicated across multiple cohorts

• SYP, CREB: Synaptic plasticity genes with reduced expression

Hypomethylated genes (activated in AD):

• **BACE1 can slow epigenetic aging

DNA Methylation in Other Neurodegenerative Diseases

Parkinson’s Disease

• Altered methylation at the SNCA locus: hypomethylation of SNCA intron 1 increases alpha-synuclein expression

• LRRK2 and GBA methylation changes in PD blood and brain

• Accelerated epigenetic aging in substantia nigra dopaminergic neurons

ALS

• C9orf72 repeat expansion carriers show hypermethylation of the C9orf72 promoter

• Aberrant methylation of SOD1 and TARDBP loci

• Epigenetic aging of motor Neurons in ALS

Huntington’s Disease

• Altered methylation patterns near the HTT locus in Huntington’s disease

• Accelerated epigenetic aging in striatal tissue correlates with CAG repeat length

Therapeutic Implications

Pharmacological Approaches

DNMT inhibitors:

• 5-azacytidine (Vidaza) and decitabine: FDA-approved for hematological malignancies; preclinical AD studies show mixed results

• RG108: Non-nucleoside DNMT inhibitor with improved safety profile

• Challenges: Lack of gene specificity; global demethylation may activate deleterious genes

TET enzyme modulators:

• Vitamin C enhances TET enzyme activity and promotes 5hmC formation

• Restoring 5hmC levels may be therapeutically beneficial in AD

HDAC inhibitors]:

• Interact with DNA methylation pathways; combined epigenetic therapy approaches under investigation

Precision Epigenetic Editing

• CRISPR-dCas9-DNMT3A: Targeted methylation of specific genomic loci without altering DNA sequence

• CRISPR-dCas9-TET1: Targeted demethylation for reactivating silenced genes

• Proof-of-concept in neuronal cultures; delivery challenges for CNS applications

Lifestyle and Dietary Interventions

Modifiable factors that influence brain DNA methylation:

• Methyl donors: Folate, vitamin B12, B6, choline, betaine — support SAM synthesis for methylation reactions

• Exercise: Aerobic exercise modulates DNA methylation at BDNF and inflammatory gene loci

• Mediterranean diet: Associated with slower epigenetic aging

• Cognitive engagement: Learning and enrichment drive activity-dependent methylation changes

• Sleep: Sleep disruption alters circadian methylation patterns

External Links

• NIH Roadmap Epigenomics

Background

The study of Dna Methylation has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying [mechanisms of neurodegeneration/mechanisms) and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Brain Atlas Resources

• Allen Human Brain Atlas: DNA Methylation expression search

• Allen Mouse Brain Atlas: DNA Methylation search

• Allen Cell Type Atlas: Transcriptomic cell type reference

• BrainSpan Developmental Transcriptome: DNA Methylation developmental expression

See Also

• Neurons

• Astrocytes

• BDNF

• alpha-synuclein

• Alzheimer’s Disease

• Parkinson’s Disease

• ALS

• Huntington’s Disease

• Microglia

• neuroinflammation